Sepracor-Looks very promising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (2807)	5/17/1999 3:30:00 PM
From: quidditch	Read Replies (1) of 10280

Peter, you mentioned that the Nori data wasn't "powered" to disclose Loratadine comparisons. What was your take of the "incidental" comparison of onset of action and histamine binding information posted on SEPR's site (which certainly seemed to be favorable). Are you saying the trial wasn't structured as a comp, and that the charts simply juxtapose independently derived data in different clinical settings (which was my take)? Regards. Steven

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next